Compared with other groups, treatment with IL-12 and 4D5 significantly inhibited the growth of colorectal adenocarcinoma constructed in BALB/c mice expressing human HER2 (CT-26 HER2/neu) and reduced the tumor volume by approximately 70%. This evidence concerns the gene ERBB2 and colorectal adenocarcinoma.